ArticleFrontiers in endocrinology2026
Development and validation of a nomogram model for predicting unplanned readmission in patients with acute pancreatitis.
Article in Frontiers in endocrinology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: The objective of this study was to develop and validate a nomogram for predicting 1-year unplanned readmission in patients with acute pancreatitis (AP) to identify high-risk populations. Methods: We retrospectively selected 474 AP patients who were treated and discharged from the First People's Hospital of Linping District, Hangzhou City, from 1 January 2021 to 31 December 2023. These patients were randomly divided into a training cohort ( Results: Within 1 year, the incidence of unplanned readmission was 36.1% (120/332) in the training cohort, 40.1% (57/142) in the internal validation cohort, and 42.7% (93/218) in the external validation cohort. Six independent predictors of unplanned readmission in patients with AP were identified, including biliary AP, diabetes, alcohol, infected pancreatic necrosis (IPN) at first admission, acute peripancreatic fluid collection (APFC), and readmission score. The nomogram demonstrated sufficient predictive accuracy, with area under the curve (AUC) values of 0.739 (95% confidence interval [CI]: 0.684-0.794), 0.836 (95% CI: 0.770-0.902), and 0.704 (95% CI: 0.636-0.772) in the training cohort, internal validation cohort, and external validation cohort, respectively. The calibration curve showed good agreement between the predicted risk and the actual risk observed. Conclusions: The nomogram developed in this study demonstrates good predictive value for unplanned readmission in patients with AP and may help identify high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.